Evaluating Treatment from the Point of View of the Patient - PROs (Patient-Reported Outcomes)

被引:6
|
作者
Boerdlein-Wahl, Inge [1 ]
Hilpert, Felix [2 ]
Kohlmann, Thomas [3 ]
机构
[1] Mamazone Sudw, Ladenburg, Germany
[2] Univ Klinikum Schleswig Holstein, Klin Gynakol & Geburtshilfe, Kiel, Germany
[3] Inst Community Med, Abt Methoden Community Med, Greifswald, Germany
来源
ONKOLOGIE | 2009年 / 32卷
关键词
Patient-reported outcomes; Clinician-reported outcomes; Health-related quality of life; Ovarian cancer; Coping strategy; ADVANCED OVARIAN-CANCER; 1ST-LINE TREATMENT; CARBOPLATIN/PACLITAXEL; CHEMOTHERAPY; LIFE;
D O I
10.1159/000215717
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The patient's own evaluation of treatment can simplify communication between the patient and the treating physician; it provides additional important information for therapy control and improves patient compliance. Patient-reported outcomes (PROs) have already been examined in clinical studies among patients suffering from advanced ovarian cancer for a long time now and have made an important contribution with respect to the definition of a recognized standard of treatment for first-line therapy. This article describes the significance of PROs from the point of view of a social scientist, a gynaecologist, and an affected patient.
引用
收藏
页码:18 / 20
页数:3
相关论文
共 50 条
  • [31] Patient-reported outcomes (PROs) in pancreatic cancer clinical trials (CTs)
    Grewal, Udhayvir Singh
    Ahmed, Danya
    Dhaliwal, Lovekirat Singh
    Laheru, Daniel A.
    Lou, Emil
    Beg, Muhammad Shaalan
    Nipp, Ryan David
    Gupta, Arjun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [32] PATIENT-REPORTED OUTCOMES (PROS) IN ANTINEOPLASTIC PRODUCT APPROVALS IN EUROPE AND IN THE USA
    Patrick, D.
    Acquadro, C.
    Teschendorf, B.
    Emery, M. P.
    Caron, M.
    Arnould, B.
    VALUE IN HEALTH, 2012, 15 (07) : A431 - A431
  • [33] The Digital Transformation of Patient-Reported Outcomes' (PROs) Functionality Within Healthcare
    Eriksen, Jeppe
    Bertelsen, Pernille
    Bygholm, Ann
    DIGITAL PERSONALIZED HEALTH AND MEDICINE, 2020, 270 : 1051 - 1055
  • [34] Evaluating clinical and patient-reported outcomes (PROs) for patients with diabetes participating in a comprehensive disease management program
    Pinto, S. L.
    Morgan, E. E.
    VALUE IN HEALTH, 2007, 10 (06) : A276 - A276
  • [35] Which formats for communicating patient-reported outcomes (PROs) work best?
    Brundage, Michael Donald
    Bantug, Elissa Thorner
    Little, Emily Anne
    Smith, Katherine Clegg
    Snyder, Claire Frances
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Patient-reported outcomes (PROs) in lung cancer: Experiences from a nationwide feasibility study
    Bronserud, Majken M.
    Iachina, Maria
    Green, Anders
    Groenvold, Mogens
    Dorflinger, Liv
    Jakobsen, Erik
    LUNG CANCER, 2019, 128 : 67 - 73
  • [37] Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps
    Afroz, Nuzhat
    Gutzwiller, Florian S.
    Mackay, Alex J.
    Naujoks, Christel
    Patalano, Francesco
    Kostikas, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1789 - 1800
  • [38] Genetic profile and patient-reported outcomes (PROs) in COPD: a systematic review
    Melro, Helder
    Moura, Gabriela
    Marques, Alda Sofia Pires De Dias
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [39] PATIENT-REPORTED OUTCOMES (PROS) IN ANTIDIABETIC PRODUCT APPROVALS IN EUROPE AND IN THE USA
    Caron, M.
    Emery, M. P.
    Perrier, L. L.
    Acquadro, C.
    Escanez-Virieux, M. P.
    VALUE IN HEALTH, 2013, 16 (03) : A169 - A170
  • [40] Prognostic value of patient-reported outcomes (PROs) in advanced cancer.
    Patel, Shiven B.
    Akerley, Wallace L.
    Ose, Dominik
    Haydell, Tyler
    Martineau, Jim
    Dunson, William A.
    Chalmers, Anna Weinberg
    Cannon, Laura
    Meropol, Neal J.
    Haaland, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)